News & Updates

A two-year-old child born with HIV infection and treated with antiretroviral drugs beginning in the first days of life no longer has detectable levels of virus using conventional testing despite not taking HIV medication for 10 months, according to findings presented today at the Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta.

For more than 30 years, a major goal of NICHD has been to reduce MTCT of HIV and other infections. Institute-supported research has identified practices and drug combinations that are very effective in preventing MTCT of HIV. As a result of this research, transmission rates in the United States have dropped to less than 1%.

An immune system protein normally found in semen appears to enhance the spread of HIV to tissue from the uterine cervix, according to researchers at the National Institutes of Health.

On December 5, 2012, the NICHD released the Scientific Vision: The Next Decade, the culmination of a collaborative process that began in 2011 to identify the most promising scientific opportunities for the Institute and the research community to pursue over the next decade. The Vision statement was made available during the NICHD’s 50th anniversary colloquium.

​Alan Guttmacher, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announced a number of changes to streamline the institute’s organizational structure and accelerate the exchange of scientific ideas.

A document charting a research course for the many collaborators who share an interest in promoting the science concerning human development through the life span, child health, women's health, and rehabilitation research is now available online.

As the Institute marks its golden anniversary, we look back on the NICHD's early years, its scientific accomplishments, and its future.

According to the World Health Organization (WHO), more than 34 million people around the world are living with HIV, and about 10% of them are children. On World AIDS Day, the NICHD reflects on its progress and its continuing efforts to keep these children healthy, to preserve the health of HIV-positive mothers, and to prevent new cases of HIV among children and adults.

​A combination of anti-HIV drugs has been found to also reduce the risk of recurrent malaria by nearly half among HIV-positive children, according to researchers supported by the National Institutes of Health.

​Roughly 20 percent of youth who have had HIV since birth did not know their HIV status when they first became sexually active, according to a study by a National Institutes of Health-supported research network.

​Women with HIV may benefit from a vaccine for human papillomavirus (HPV), despite having already been exposed to HPV, a study finds. Although many may have been exposed to less serious forms of HPV, more than 45 percent of sexually active young women who have acquired HIV appear never to have been exposed to the most common high-risk forms of HPV, according to the study from a National Institutes of Health research network.

​Lynne Mofenson, M.D., Chief of the Pediatric, Adolescent and Maternal AIDS Branch, received the Federal Employee of the Year Award from the Partnership for Public Service. The award is one of nine Samuel J. Heyman Service to America Medals bestowed on public servants who make "high-impact contributions to the health, safety and well-being of Americans."

The International AIDS Society has convened its important gathering of more than 20,000 scientists, public health experts, policy makers, individuals and members of communities affected by HIV/AIDS, and media representatives annually since 1985.

The July 2012 NICHD Research Perspectives, the NICHD’s monthly podcast, is now online.  This month’s podcast features research sponsored by the NICHD’s Pediatric, Adolescent and Maternal AIDS Branch.

Adding the drug nevirapine to the regimen given to newborns of women diagnosed with HIV shortly before or during labor halves the newborns' risk of contracting the virus, according to findings by a National Institutes of Health research network.

Children exposed to HIV in the womb may be more likely to experience hearing loss by age 16 than are their unexposed peers, according to scientists in a National Institutes of Health research network.

Young men being treated for HIV are more likely to experience low bone mass than are other men their age, according to results from a research network supported by the National Institutes of Health. The findings indicate that physicians who care for these patients should monitor them regularly for signs of bone thinning, which could foretell a risk for fractures. The young men in the study did not have HIV at birth and had been diagnosed with HIV an average of two years earlier.

Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study.

HIV/AIDS continues to be a serious public health concern. According to the Centers for Disease Control and Prevention (CDC), more than 290,000 women were living with HIV in the United States in 2008.

Children exposed to HIV before birth are at risk for language impairments, according to a study by researchers at the National Institutes of Health and other institutions.